{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:51:12Z","timestamp":1790923872303,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ahj.2007.10.046","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T11:27:31Z","timestamp":1203679651000},"page":"687-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"title":["The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial"],"prefix":"10.1016","volume":"155","author":[{"given":"Patricia J.M.","family":"Best","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Steinhubl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda A.","family":"Szczech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Califf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Topol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2007.10.046_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2007.10.046_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.10.046_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.10.046_bib4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.ahj.2007.10.046_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-3848(96)00145-4","article-title":"Hemostasis, platelet function and serotonin in acute and chronic renal failure","volume":"83","author":"Malyszko","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2007.10.046_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(85)90051-8","article-title":"Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis","volume":"79","author":"Di Minno","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2007.10.046_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.2830350306","article-title":"Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets","volume":"35","author":"Soslau","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ahj.2007.10.046_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0038-1647640","article-title":"Platelet function and the bleeding time in progressive renal failure","volume":"60","author":"Gordge","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2007.10.046_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1650576","article-title":"Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, us correlated with indices of activation of coagulation and fibrinolysis","volume":"76","author":"Mezzano","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2007.10.046_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0049-3848(97)00280-6","article-title":"Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure","volume":"88","author":"Mezzano","year":"1997","journal-title":"Thromb Res"},{"key":"10.1016\/j.ahj.2007.10.046_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2007.10.046_bib12","first-page":"S17","article-title":"Executive summary\u2014K\/DOQI clinical practice guidelines","volume":"39","author":"Anonymous","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2007.10.046_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Anonymous","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.10.046_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9149(02)02567-5","article-title":"Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus","volume":"90","author":"Bhatt","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.10.046_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Clopidogrel in Unstable angina to prevent Recurrent Events Trial Investigators. Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.10.046_bib16","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.10.046_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1018758308979","article-title":"A pharmacodynamic study of clopidogrel in chronic hemodialysis patients","volume":"10","author":"Kaufman","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2007.10.046_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1160\/TH04-02-0105","article-title":"Pharmacokinetics of clopidogrel after administration of a high loading dose","volume":"92","author":"Taubert","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2007.10.046_bib19","first-page":"21","article-title":"Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?","volume":"59","author":"Soffer","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2007.10.046_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.hjr.0000220582.19516.a6","article-title":"Renal function and outcomes in acute coronary syndrome: impact of clopidogrel","volume":"14","author":"Keltai","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ahj.2007.10.046_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2007.10.046_bib22","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V94.8.2569.420k13_2569_2574","article-title":"Uremic bleeding: closing the circle after 30 years of controversies?","volume":"94","author":"Noris","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ahj.2007.10.046_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1067\/mhj.2003.168","article-title":"Anticoagulation in acute cardiac care in patients with chronic kidney disease","volume":"145","author":"Reddan","year":"2003","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307009866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307009866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:34:04Z","timestamp":1757568844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870307009866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0002870307009866"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2007.10.046","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2007.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}